International Clinical Trial: FIDAA - Understanding the Experience of People Receiving Escalating Financial Incentives for the Testing and Uptake of Direct Acting Antivirals for Hepatitis C - A Feasibility Study

Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001040358) titled 'FIDAA - Understanding the Experience of People Receiving Escalating Financial Incentives for the Testing and Uptake of Direct Acting Antivirals for Hepatitis C - A Feasibility Study' on Aug. 24.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Single group Type of endpoint: Efficacy

Primary Sponsor: Hunter New England Local Health District

Condition: Hepatitis C Hepatitis C Public Health - Health promotion/education Infection - Other infectious diseases Oral and Gastrointestinal - Other diseases of the mouth, teeth, o...